EKF Diagnostics Holdings plc
EKF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -4.6% | -21% | -18.6% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 42.8% | 45.3% | 36.1% | 48.1% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | -£0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | -£0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | £0 | £0 | £0 | £0 |
| % Margin | 12.9% | 4% | 11.4% | 26.6% |
| Other Income/Exp. Net | -£0 | £0 | -£0 | -£0 |
| Pre-Tax Income | £0 | £0 | -£0 | £0 |
| Tax Expense | -£0 | -£0 | £0 | £0 |
| Net Income | £0 | £0 | -£0 | £0 |
| % Margin | 12.4% | 4.5% | -15.2% | 19.4% |
| EPS | 0.014 | 0.005 | -0.022 | 0.035 |
| % Growth | 165.4% | 123.5% | -163.7% | – |
| EPS Diluted | 0.014 | 0.005 | -0.022 | 0.034 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | £0 | -£0 | £0 |
| % Margin | 22.2% | 14.6% | -3.3% | 33.5% |